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Abstract 
 Background: The influence of body weight on serum lipids and uric 
acid is often overlooked in clinical practice. 
Objective:  To study the magnitude of metabolic disorders (dyslipidemia 
and hyper-urecaemia) in asymptomatic obese men and its relation to body 
mass index (BMI). 
Methods: The study was conducted between September 2013 and July of 
2014 at the medical analyses center in the Faculty of Public Health, 
Lebanese University. The weight, height, BMI, waist circumference (WC) 
uric acid, and lipid profile of 148 obese males, apparently healthy, compared 
with 80 males in a control group (BMI < 25 kg / m²), were investigated. 
Subjects were grouped by BMI and WC in accordance with the National 
Institutes of Health cutoff points. Within the normal-weight (18.5-24.9), 
overweight (25.0-29.9), and obese (≥ 30.0) BMI categories, we distributed 
the results of all the blood tests and we computed the prevalence of 
dyslipidemia and hyperurecaemia. 
Results: The present work revealed that with increasing body weight, the 
mean total cholesterol, LDL-C, triglycerides(TG), and uric acid increased; 
while the mean HDL-C decreased. These changes were as follows: the 
means difference between the first and second group and between the second 
and the third group were 29 and 31 mg/dl respectively regarding total 
cholesterol; for TG, these were 47.5 and 53.4 mg/dl; for LDL-C, these were 
12 and 29 mg/dl; for HDL-C, these were 3.6 and 3.5 mg/dl; for uric acid, 
these were 0.3 mg/dl as a common difference, P=0.0245).  
Conclusion: Excess body weight is associated with deleterious changes in 
the lipoprotein profile  and uric acid. 
 
Keywords: Metabolic disorders, obesity, Bodi Mass Index 
 
Introduction:  
 Obesity is an excessive accumulation of energy in the form of body 
fat which impairs health.The main cause of obesity epidemic is clear: 
overeating, especially that of foods, which are rich in fats, extracted sugars 
or refined starches. This combined with decline in physical activity results in 
an imbalance of intake and expenditure of calories, resulting in excess 
weight and eventually obesity. Co-morbidities commonly associated with 
obesity include diabetes,cardiovascular and respiratory disease, 
dyslipidemia, degenerative joint disease, stress incontinence and some form 
of tumors and other various diseases. Dyslipidemia is a widely accepted risk 
factor for coronary artery disease and is an important feature of metabolic 
syndrome. Obesity especially visceral obesity causes insulin resistance and is 
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associated with dyslipidemia, impaired glucose metabolism, and 
hypertension all of which exacerbate atherosclerosis. The primary 
dyslipidemia related to obesity is characterized by increased triglycerides, 
decreased high density lipoprotein levels and abnormal low density 
lipoprotein composition. Weight loss and exercise, even if they do not result 
in normalization of body weight, can improve this dyslipidemia and thus 
reduce cardiovascular risk. In addition, obese individuals needed to be 
targeted for intense lipid lowering therapy, when necessary( AK Singh, 
2011),  (Sharma S. K , 2011)(Misra A, 2008); (Gupta R, 2002), (Gupta R,, 
2007) 
 Obesity is an increasing health issue worldwide and an economical 
burden, and as the hallmark of the metabolic syndrome the obese state is 
frequently associated with the development of chronic diseases, including 
type 2 diabetes  (James WP,2008) ,( Wellen KE, 2005) .The association 
between the epidemics of obesity and diabetes has promoted research on the 
endocrine link between lipid and glucose homeostasis, demonstrating that 
adipose tissue is an endocrine organ releasing various adipokines. 
(SellH,2013). 
Metabolic syndrome is defined as a group of coexisting metabolic 
risk factors, such as central obesity, lipid disorders, carbohydrate disorders, 
and arterial hypertension (M. Janghorbani,2012), (V. Altabas2012) 
Those factors increase the risk of developing cardiovascular diseases 
of atherosclerotic etiology and diabetes mellitus type 2 ,which are the main 
cause of premature deaths among most of the European and US population  ( 
E.S.Ford, 2004 ) 
Metabolic syndrome is defined as a group of coexisting metabolic 
risk factors, such as central obesity, lipid disorders, carbohydrate disorders, 
and arterial hypertension. (According to the 2005 IDF criteria, subsequently 
revised in 2009, abdominal obesity is identified as the waist circumference of 
≥80 cm in women and ≥94 cm in men. It is responsible for the development 
of insulin resistance. The number of patients with metabolic syndrome 
increases with age. In the US population, the percentage of such patients 
above the age of 20 is approximately 23%, while the percentage of such 
patients above 60 is approximately 40%(M. Shields, 2012).Abdominal 
obesity is the major disorder constituting a base for the development of 
metabolic syndrome. BMI is the simplest, most practical, and most widely 
used system of indexing body weight. It is defined as body weight (in 
kilograms) divided by the square of body height (in metres).The index 
divides patients into appropriate categories: underweight, normal weight, 
overweight, and obese. Even though BMI is commonly used for monitoring 
the occurrence of obesity in the population, it has numerous limitations. It 
does not provide any information on the distribution of the adipose tissue in 
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the organism. BMI is a calculated statistical value which does not take into 
consideration physiological differences in the proportions between the 
adipose, osseous, and muscular tissues (M. Shields, 2012).Besides, its value 
is affected by sex,age, constitution, and training. Evidence from the 
conducted studies has revealed that abdominal obesity (assessed based on the 
waist circumference) plays a very important role in the development of 
metabolic disorders and in the assessment of cardiovascular risk. According 
to the 2005 IDF criteria, subsequently revised in 2009, abdominal obesity is 
identified as the waist circumference of ≥80 cm in women and ≥94 cm in 
men. It is responsible for the development of insulin resistance (Marcin 
Gierach, 2014). Obesity has become an increasing public health problem 
internationally (Obesity: World Health Organ Tech Rep Ser 2000).Attention 
has been given to the adverse health consequences of a moderate increase in 
body mass index (BMI) in different ethnic groups (WHO consultation. 
2000); ( Kumanyika SK.1993) .Several lines of evidence indicate that the 
distribution of fat is a major determinant of cardiovascular risk in both 
normal weight, overweight and moderately obese (Larsson B 1984), 
Schneider HJ(2010)Australia, Brazil, China, Mauritius and Western Samoa 
Overweight and obesity are linked to a host of chronic disorders, 
including hypertension, hyperlipidemia, diabetes mellitus and osteoarthritis. 
The prevalence of overweight has been reported to be increasing in varying 
degrees, not only in the United States, but also in Britain and elsewhere in 
Europe, as well as in countries as diverse as Australia, Brazil, China, 
Mauritius and Western Samoa.  (KM Flegal, 1998)  
 
Aim of the work: 
The aim of the present work was to study the correlation between the 
level of nutritional obesity represented by the body mass index (BMI) in 
adult men (18 year and above) and the serum levels for the total 
cholesterol(TC), triglycerides (TG), low-density lipopolysaccharide 
cholesterol (LDL-C), high density lipopolysaccharide cholesterol (HDL-C), 
fasting blood glucose and uric acids. 
 
Material and methods: 
The study was done at the department of laboratory in the faculty of 
public health, Lebanese university.  
This study included 248 adult men divided into three groups 
according to their body mass index.  
Group I: 80 normal weight men (BMI < 25 kg/m²) considered as 
Controls. 
Group II: 88 overweight men (BMI between25 and 30 kg/m2). 
Group III: 80 obese men (BMI ≥ 30 kg/m2). 
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Inclusion criteria: Persons above 18 year 
Exclusion criteria: 
• Persons with endocrine diseases as Cushing's syndrome. 
• Persons with diabetes mellitus, or even those with Impaired 
Fasting Glucose (IFG) according to the classification of the 
American Diabetes Association (ADA) (fasting glucose 100-
125 mg/dl). 
• Persons with cardiovascular disease as ischaemic heart 
disease, hypertension or familial hypercholesterolaemia. 
• Persons with renal diseases as Nephrotic syndrome or chronic 
renal failure. 
• Persons with family history of blood lipids disorder, 
ischaemic heart disease, diabetes, hypertension or obesity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
Chart 1: Distribution of the study groups 
 
 Venous blood samples were collected from each subject on an empty 
stomach after a fasting period at least 12 hours and after a rest period of 
more than 15 minutes. Then each sample is centrifuged to get the patient's 
serum and the samples were  preserved frozen at-20 ° C for a period of less 
than two months (can be saved at -20 for a maximum term of three months) 
and then thawed to room temperature directly before the measurement. 
Each person had the following measurements: the total 
cholesterol(TC), triglycerides (TG), low-density lipopolysaccharide 
cholesterol (LDL-C), high density lipopolysaccharide cholesterol (HDL-C), 
fasting blood glucose and uric acids. 
 
32%
36%
32%
Study groups
Normal controls
Overweight
Obese
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The standards used in this study are those known universally and are 
outlined in the following  table 
Values in mg/dl Normal Limit High 
Total Cholesterol ˂ 200 200-239 ≥ 240 
LDL-C ˂ 130 130-159 ≥ 160 
HDL-C ˂ 35   
TG ˂ 160 160-200 ˃ 200 
Table 1: recommended world-wide standards according to the NECP 
 
While the uric acid levels were considered high when the serum 
levels exceeded 6mg/dl. 
Also fasting blood glucose were considered high when their level 
exceeded 126 mg/dl. 
After getting the results of chemical analysis, we used statistical 
analysis software SPSS for the mean and the standard deviation of each of 
the variables examined in each group. 
In addition to that the statistical Grubb' test was used to detect numbers 
far from mean values (Outliers) so as to exclude them before any statistical 
test. 
 
A. Results: 
The present study revealed the following results: 
Table 1: 
BMI (kg/m2) TC HDL-C LDL-C TG Uric acid 
Normal weight 
(Mean± SD) 184±40 49.15±10.2 124.88±35 131.86±73 5.54±1 
Overweight  
(Mean± SD) 213.5±45 45.5±9.7 136.5±39.75 179.35±74.6 5.9±1.6 
Obese  
(Mean± SD) 244.27±43.51 41.93±8.7 165.5±33.43 232.75±98.8 6.2±1.34 
 
 1.Total cholesterol: Table I shows that the difference between the 
average values of total cholesterol is about 29 mg/dl higher in group II than 
group I and this difference is statistically significant (P < 0.0001); and 31 
mg/dl higher in group III than group II which is also statistically significant 
difference (P < 0.0001). 
  This indicates that higher weight is associated with high serum level 
of total cholesterol. 
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Chart …… : Total cholesterol changes with BMI 
 
Triglycerides: Table I shows that the difference between the average 
values of triglycerides is about 47.5 mg/dl  higher in group II than group I 
and this difference is statistically significant (P < 0.0001); and 53.4 mg/dl 
higher in group III than group II which is also statistically significant 
difference (P < 0.0001). This indicates that higher weight is associated with 
high serum level of triglycerides. 
 
Comparing the means for trigycerides: 
 
Chart …….:  Total TG changes with BMI 
 
3. low-density lipopolysaccharide cholesterol (LDL-C): Table I 
shows that the difference between the average values of LDL-C is about 11.6 
mg/dl  higher in group II than group I and this difference is statistically 
significant (P<0.0469); and and 29 mg/dl higher in group III than group II 
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which is also statistically significant difference (P < 0.0001). This indicates 
that higher weight is associated with high serum level of LDL-C. 
 
Comparing the means for LDL-C 
 
Chart ……… :  Total LDL-C changes with BMI 
 
 4. High density lipopolysaccharide cholesterol (HDL-C): Table I 
shows that the difference between the average values of (HDL-C) is about 
3.6 mg/dl lower in group II than group I and this difference is statistically 
significant (P < 0.0168); and 3.5 mg/dl lower in group III than group II 
which is also statistically significant difference (P < 0.0133). This indicates 
that higher weight is associated with low serum level of HDL-C. 
 
Comparing the means of HDL-C  
 
Chart3: Total HDL-C changes with BMI 
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5. Serum uric acid: Table I shows that the difference between the 
average values of uric acid is approximately 0.36 mg/dl higher in group II 
than group I and the difference is not statistically significant (P < 0.0857), 
and 0.3 mg/dl higher in group III than group II which is not also statistically 
significant (also P < 0.1919). This indicates that higher weight is associated 
with slight increase in the serum level of uric acid, without statistical 
significance. 
 
Comparing the means for Uric acid 
 
Chart6:  Total uric acid changes with BMI 
 
1. Comparison of metabolic disorders prevalence rates 
between the three groups: 
By calculating the prevalence of metabolic disorders seen in obese 
and overweight men and comparing them with standard weight group 
(Controls) and placing the results in tables we get the following data: 
% of prevalence Group I 
Normal 
weight 
Group II 
Overweight 
Group III 
Obese 
Total Cholesterol-High 23.1 25 59.3 
Total Cholesterol-Borderline 19.6 38 26.5 
LDL-C- High 6.6 21.4 62.5 
LDL-C- Borderline 14.7 31 21.8 
HDL-C-low 1.25 15.4 29.68 
TG High 6.3 31 51.5 
Hyperurecaemia 7.5 26.2 37.5 
    
Table3:  % of prevalence of metabolic disorders according to the BMI 
5,54 5,9 
6,2 
0
1
2
3
4
5
6
7
8
Mean Uric acid
m
g/
dl
 BMI-Normal
BMI-Overweight
BMI-Obese
European Scientific Journal October 2015 /SPECIAL/ edition Vol.2   ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
 
211 
Chart 7: % of prevalence of metabolic disorders according to the BMI 
 
1. This figure shows that the prevalence of metabolic disorders 
is higher in the overweight and obese group as compared with 
the control normal weight group.  
 
Studying the correlation between the BMI and each of the studied 
variables 
Correlation coefficient of  Pearson was used and the results were as 
follows 
a) Correlation between the BMI and TC   
The relation between BMI and TC was linear and positive (r=0.69) 
 
Figure1:  Correlation between BMI and total cholesterol 
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b) Correlation between the BMI and LDL-C 
The relation between BMI and LDL-C was linear and positive (r=0.59) 
 
Figure2:  Correlation between BMI and LDL-C values 
 
c) Correlation between the BMI and HDL-C 
The relation between BMI and HDL-C was linear and negative, but not 
strong (r=-0.549) 
 
Figure3:  Correlation between BMI and HDL-C values 
 
d) Correlation between the BMI and TG 
The relation between BMI and TG was linear and positive (r=0.66) 
 
Figure4:  Correlation between BMI and TG value 
 
e) Correlation between the BMI and Uric acid 
The relation between BMI and Uric acid was linear and weak (r=0.34) 
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Figure5:  Correlation between BMI and uric acid value. 
 
Discussion: 
1. Accompanying the increased weight with:  
• higher values for serum levels of total cholesterol, TG, 
LDL-C lower level values a worshipper of HDL-C.  
• Higher values for serum levels of uric acid level, but 
the results were not statistically significant. 
• The prevalence of higher serum levels of total 
cholesterol, TG, LDL-C and uric acid is higher when 
overweight and obese are compared to controls; and 
obese is higher compared to overweight.          And the 
frequency of the low level HDL-C was higher when 
overweight and obese compared with controls, and 
higher when compared with obese overweight.  
2. The relationship between positive function of increasing 
weight and level of total cholesterol, TG, LDL-C and reverse 
with the level HDL-C.         
3.  The relationship between increased weight and level of 
serum uric acid was positive and weak. 
 
B. Comparative local studies 
We did not find any local search is similar to research this and all we 
found was a search soon for his maysaa al Hamwi 2002 examined where 
fat and lipoprotein disorders  in different types of obesity and its relation 
to cardiovascular injury frequency.  Dr. Hamwi found  the existence of a 
direct correlation between the levels of both TG and LDL-C and BMI; 
and the existence of an inverse relationship between HDL-C and BMI 
levels. Note that the study included both genders and family and non-
family obesity. 
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C. Comparative international studies 
1. Munster heart study: published by PROCAM (Groupe de 
reflexion international pour la prevention des maladies 
coronarienne) in an article entitled. Maladies coronarienne: 
reduire lerisque. 
The study included 12,231 men classified in 5 groups of BMI 
(kg/m2) are: 1. BMI ≤ 20.  2- BMI ( 20.1 – 25). 3- BMI ( 25.1 
– 27.5) 4- BMI ( 27.6 – 30). 5- BMI > 30. The findings of this 
study is huge, as follows: 
BMI (kg/m2) Mean LDL-C 
(mg/dl) 
Mean HDL-C 
(mg/dl) 
Mean TG 
(mg/dl) 
≤ 20 122 53.3 92 
20.1-25 136 47.8 106 
25.1-27.5 141 44.7 129 
27.6-30 142 42.5 151 
> 30 143 40 172 
 
This study showed, in turn, the role and influence of weight 
measurements of grease and lipoproteins in the blood. This 
message indicates (because of the large sample studied 
allowed broader classification for men by BMI) that this 
impact continues even in ideal weight objects (De forme) and 
slender objects (Maigre) as evidenced by the results of this 
study. 
2. A study by the National Health and Nutrition Examination 
Survey and Panel III (NHANES III); 1988-1994 17: body 
mass index BMI and the prevalence of risk factors in 
cardiovascular disease.             
Researchers examined the prevalence of high blood 
cholesterol, high LDL-C, low HDL-C, high triglycerides TG, 
and its relationship with BMI. The men were classified in four 
groups as follows: 1. BMI < 25.  2- BMI (25 – 26). 3- BMI(27 
– 29 ). 4- BMI ≤ 30.     And the results were as follows: 
• Increased body weight was associated with higher 
levels of total cholesterol.  
• Increased body weight of BMI ≤ 21 to BMI ≥ 30 was 
associated with higher serum levels of the TG. (The 
difference between these levels ranged from 62 to 118 
mg/dl).  
• Statistical studies have found that changes in BMI is 
associated with changes in the level of serum HDL-C, 
noting that1 unit change in the BMI is associated with 
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change in level of serum HDL-C with an average of 
1.1 mg/dl.  
• Studies have also found that the 10 units increase in 
the BMI is associated with a high rate (between 10 to 
20 mg/dl) in the level LDL-C. 
3.   Research conducted at the University of Texas, United 
States 5, titled "Excess body weight. An under recognized 
contributor to high blood cholesterol levels in white American 
men " to study the influence caused by overweight fat level in 
the serum lipids. Test results were distributed among the 
different types of BMI.  The study showed that overweight is 
associated with Deleterious health damaging changes in levels 
of serum lipoproteins, since the high BMI at all ages is 
associated with a higher level of the TG, total cholesterol, TG 
and non-HDL-C; and a lower level of the serum HDL-C 
 
D. Recommendations 
-The need to maintain an ideal Body Weight to improve the level of 
triglycerides and blood lipoproteins in order to be at a lower risk for arterial 
disease and coronary heart and other diseases that have proved their impact 
on health and life. 
-Encourage people, especially children in the critical stages of their 
development, to participate   more in sports and away from sedentary life 
style and to avoid weight gain and  obesity. 
-Impose strict measures on all products with high caloric intake as 
did United Kingdom UK by imposing higher taxes on these articles. 
- Adoption of marginal figures Cutoff  Points for serum levels of total 
cholesterol and LDL-C and HDL-C and other studies by the NECP and the 
national institutes of health (NIH). 
- Raising awareness of citizens about the dangers of obesity through 
media, seminars and lectures. 
-The need for further studies to complement this study deals with the 
comparison of serum level of leptin in obese and non-obese. 
-Complementary studies looking at the impact of reducing body 
weight on the levels fats and serum lipoproteins. 
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